Subventricular Zone radiation for glioblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Jun 2014: Trial registered, NCT02177578
  2. 8 Jul 2014: Trial started, NCT02177578

The trials

NCT02177578: Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

State
Under way
Phase
Phase 2
People
60 planned
Started
8 Jul 2014
Primary completion
Apr 2027
Arms
Temozolomide plus radiation therapy to the tumor and SVZ
Results
None posted
  1. 27 Jun 2014: Trial registered
  2. 8 Jul 2014: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.